Abstract
Peptides effective as delta opioid receptor agonists and compositions comprising same are provided. Further provided are methods for targeting medical conditions amenable to treatment with an opioid receptor agonist, including but not limited to, conditions involving pain as well as reducing cocaine craving.
Original language | English |
---|---|
Patent number | US10421785B2 |
State | Published - 1 Sep 2019 |